Reyataz
Product Images NDC 54868-5838

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Reyataz (NDC 54868-5838). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Reyataz 150-mg Capsules (4857)

Reyataz 150-mg Capsules (4857)
Label for REYATAZ 150 mg capsules distributed by Physicians Total Care, Inc. The label includes the NDC 54868-4857-0, a lot number, expiration date listed as 01/60, and manufacturing by Bristol-Myers Squibb Virol in Princeton, NJ. The package count is 60 capsules.*
FDA Label Image

Reyataz 300-mg Capsules (5838)

Reyataz 300-mg Capsules (5838)
Label for REYATAZ 300 MG capsule bottle distributed by Physicians Total Care, Inc. The label includes the NDC 54868-5038-0, lot number 0000, and an expiration date listed as 01/60. Manufactured by Bristol-Myers Squibb Co., Princeton, NJ, the label also features a barcode.*
FDA Label Image

Figure 1: Mean (sd) Steady-state Plasma Concentrations Of Atazanavir 400 mg (n=13) And 300 mg With Ritonavir (n=10) For Hiv-infected Adult Patients (Reyataz Figure1)

Figure 1: Mean (sd) Steady-state Plasma Concentrations Of Atazanavir 400 mg (n=13) And 300 mg With Ritonavir (n=10) For Hiv-infected Adult Patients (Reyataz Figure1)
A pharmacokinetic graph showing Atazanavir plasma concentration (ng/mL) over time (hours) for ATV 400 mg and ATV/RTV 300/100 mg. The y-axis is logarithmic, ranging from 10 to 10,000 ng/mL. Error bars indicate variability, and a median wild-type EC90 cutoff at 14 ng/mL is marked on the chart. Sample sizes (n=10 and n=13) are noted for the two treatments.*
FDA Label Image

Atazanavir Sulfate Chemical Structure (Reyataz Structure)

Atazanavir Sulfate Chemical Structure (Reyataz Structure)
Chemical structure diagram of the active ingredient in REYATAZ depicting the molecular formula including various rings, amide bonds, and functional groups, with a sulfate (H2SO4) component shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.